PHOENIX, AZ, January 30, 2020 – Renalogic, the leader in comprehensive kidney care and dialysis cost containment, announced today Mark Masson has been promoted to President following a year of unprecedented growth for the company.
Renalogic has operated for nearly two decades around a central mission: to drive positive change for kidney disease and cost management. The company continues to be the leader in innovative services for dialysis cost containment and has proven results in delaying or preventing the progression to dialysis for its members. In 2019, Renalogic’s revenue grew over 60%, its profitability increased by 16%, and the company more than doubled its headcount.
Mark Masson joined Renalogic in 2018 with 25 years of diversified experience across the healthcare sector in operations, sales and marketing, product development, and M&A.
“Mark has utilized his strategic and execution-oriented approach to help bring our business to new heights. He is a champion for Renalogic’s vision and core values, and is a natural fit as President,” said Lisa Moody, CEO of Renalogic. “We have created the most comprehensive approach to kidney care in the industry. I am very proud of the record growth we have achieved and the difference we are making in our client’s lives.”
As Renalogic’s President, Mark will lead the company’s process teams, including sales and marketing, quality and strategy, project management, IT and data, cost containment, and the Kidney Dialysis Avoidance Program (KDAP). He will be directly responsible for supporting future business partnerships, furthering Renalogic’s organizational health initiatives in order the help drive the company’s financial health.
“I am excited to lead Renalogic’s passionate team and partners who are tireless advocates for our clients,” said Mark Masson. “Renalogic is transforming how the industry thinks about kidney care and dialysis, and I am thrilled to be at the forefront of this mission.”
Renalogic has been the industry leader in dialysis cost containment for nearly 20 years and continues to innovate through the impact of The Renalogic Chronic Kidney Disease and Diabetes Management Program. We are not abandoning dialysis cost containment. We are revolutionizing it by simplifying the costs and clinical complexities of chronic kidney disease to make a positive impact on reducing the dialysis incidence rate in every population we touch. Every chronic condition leading to kidney disease is manageable and even preventable when identified early. For more information, please visit www.renalogic.com.